Antivirals update.
D019380:Anti-HIV Agents / Q000008:administration & dosage / Q000627:therapeutic use*; D002219:Carbamates; D020008:Delavirdine / Q000627:therapeutic use; D015224:Dideoxynucleosides / Q000627:therapeutic use*; D004352:Drug Resistance, Microbial; D004359:Drug Therapy, Combination; D015507:Drugs, Investigational; D005663:Furans; D015658:HIV Infections / Q000188:drug therapy*; D017320:HIV Protease Inhibitors / Q000008:administration & dosage / Q000627:therapeutic use*; D006801:Humans; D019469:Indinavir / Q000008:administration & dosage; D019829:Nevirapine / Q000627:therapeutic use; D018894:Reverse Transcriptase Inhibitors / Q000008:administration & dosage / Q000627:therapeutic use*; D016879:Salvage Therapy; D013449:Sulfonamides / Q000627:therapeutic use*; D000099227:Abacavir
D019380:Anti-HIV Agents; D002219:Carbamates; D020008:Delavirdine; D015224:Dideoxynucleosides; D015507:Drugs, Investigational; D005663:Furans; D017320:HIV Protease Inhibitors; D019469:Indinavir; D019829:Nevirapine; D018894:Reverse Transcriptase Inhibitors; D013449:Sulfonamides; D000099227:Abacavir; C095108:amprenavir